drugset / Trial / NCT00315523

Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen

NCT00315523 ↗

Phase 3 Completed 403 enrolled UCB Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 mg, administered once daily during two consecutive days, on symptoms of seasonal allergic rhinitis occurring in subjects exposed to ragweed pollen in an environmental exposure unit.

Timeline

Start
2006-07
Primary completion
2006-10
Completion
2006-10

Outcome

Met primary endpoint

paper The MSC score in period 1 was progressively decreased to a significantly greater extent in the levocetirizine group compared with the montelukast and placebo groups. PMID 18814452 ↗

paper adjusted mean differences, -2.18 [95% confidence interval, -3.35 to -1.01; P < .001] PMID 18814452 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown 5 mg —